Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients After Hematopoietic Stem Cell Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03072771
What this trial is testing

Blinatumomab Consolidation Post Autologous Stem Cell Transplantation in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B Cell Lymphoma
Washington University School of Medicine 14
Testing effectiveness (Phase 2)Study completedNCT00028730
What this trial is testing

Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Memorial Sloan Kettering Cancer Center 25
Testing effectiveness (Phase 2)UnknownNCT00740467
What this trial is testing

Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Institut Paoli-Calmettes 50
Testing effectiveness (Phase 2)Study completedNCT00599495
What this trial is testing

Matched Unrelated Donor Stem Cell Transplantation (MUD-SCT) After Dose-reduced Conditioning for Patients With Multiple Myeloma and Relapse After Autologous SCT

Who this might be right for
Multiple Myeloma
Universitätsklinikum Hamburg-Eppendorf 50
Not applicableStudy completedNCT04423237
What this trial is testing

Risk Factors and Measures to Prevent Liver and Pancreas Complications in Pediatric Patients After HSCT

Who this might be right for
Iron Overload
University of Pisa 39
Testing effectiveness (Phase 2)Ended earlyNCT04317781
What this trial is testing

Tagraxofusp in Treating Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm After Stem Cell Transplant

Who this might be right for
Blastic Plasmacytoid Dendritic Cell Neoplasm
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Ended earlyNCT01640301
What this trial is testing

Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant

Who this might be right for
Recurrent Adult Acute Myeloid LeukemiaRecurrent Childhood Acute Myeloid LeukemiaSecondary Acute Myeloid Leukemia+5 more
Fred Hutchinson Cancer Center 47
Large-scale testing (Phase 3)Study completedNCT02327351
What this trial is testing

TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID

Who this might be right for
Primary Immune Deficiency DisorderHematopoietic Stem Cell Transplantation
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 98
Not applicableLooking for participantsNCT07685457
What this trial is testing

Evaluation of Safety and Efficacy of Virus Specific T-Cell Administration in Pediatric Patients With Systemic Viral Infection Following Allogeneic Hematopoietic Stem Cell Transplantation.

Who this might be right for
BKV InfectionCMV InfectionEBV Infection
LucasBio 6
Testing effectiveness (Phase 2)Looking for participantsNCT07269041
What this trial is testing

Immune Tolerance Induction After Liver Transplantation

Who this might be right for
Liver TransplantationImmune ToleranceImmune Tolerance/Drug Effects+6 more
University of California, Los Angeles 12
Early research (Phase 1)Study completedNCT00060372
What this trial is testing

Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+59 more
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Ended earlyNCT04623216
What this trial is testing

Sabatolimab as a Treatment for Patients With Acute Myeloid Leukemia and Presence of Measurable Residual Disease After Allogeneic Stem Cell Transplantation.

Who this might be right for
Acute Myeloid Leukemia
Novartis Pharmaceuticals 24
Testing effectiveness (Phase 2)Ended earlyNCT00827099
What this trial is testing

Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer

Who this might be right for
Myeloproliferative DisordersLeukemiaLymphoma+2 more
Northside Hospital, Inc. 5
Testing effectiveness (Phase 2)Study completedNCT03238599
What this trial is testing

Pedometer Activity Monitoring After ASCT

Who this might be right for
LymphomaMyelomaHigh-dose Chemotherapy+1 more
Insel Gruppe AG, University Hospital Bern 62
Testing effectiveness (Phase 2)UnknownNCT03611231
What this trial is testing

Chidamide Maintenance After Autologous Hematopoietic Stem Cell Transplantation for Relapsed, Refractory or High-risk Lymphoma

Who this might be right for
Experimental Tumor
Peking University 43
Testing effectiveness (Phase 2)Looking for participantsNCT07304232
What this trial is testing

Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML

Who this might be right for
Allogeneic Hematopoietic Cell Transplantation (HCT)AML (Acute Myeloid Leukemia)
Institute of Hematology & Blood Diseases Hospital, China 134
Not applicableUnknownNCT01596192
What this trial is testing

PETCT for Diagnosing and Monitoring Acute GVHD

Who this might be right for
Acute Graft Versus Host Disease
Rabin Medical Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03346135
What this trial is testing

Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Plasma Cell MyelomaSecondary Amyloidosis
City of Hope Medical Center 31
Not applicableStudy completedNCT03188419
What this trial is testing

Breadth of Donor Options for People With Inherited Diseases Requiring Allogeneic Hematopoietic Stem Cell Transplant in the Era of Alternative Donor Transplants Using Post-Transplantation Cyclophosphamide

Who this might be right for
Primary T-cell Immunodeficiency DisordersCommon Variable Immunodeficiency
National Cancer Institute (NCI) 161
Early research (Phase 1)WithdrawnNCT07498465
What this trial is testing

Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChildhood Acute Lymphoblastic Leukemia+3 more
Children's Oncology Group
Next Page